Other genes from this pathway that we found differentially expressed in our experiments are CBLC that was reported as associated with lung cancer progression (Hong et al. 2018) and CRKL which promotes tumorigenesis, cancer cell survival, and gefitinib therapy resistance in non-small cell lung cancer (Cheung et al. 2011). This evidence concerns the gene CRKL and lung carcinoma.